Quine Biologics, StableBody Technologies, and 20/15 Visioneers Announce North American and European Strategic Go-to-Market Partnership for Holistic Rational Protein Design (Al/ML-Driven, Lab Validated)
PENNSYLVANIA, NEW YORK, and WISCONSIN, May 21, 2024 /PRNewswire/-- Today, 20/15
Visioneers, a leading advanced science and technology management consulting and marketing services company along with Quine Biologics Inc., and StableBody Technologies LLC, leaders in Structure-based de-novo antibody design and experts in Rational Protein Design, is pleased to announce the collaboration and partnership to produce Next Generation Rational Protein Design for the North American and European markets.
